ArticleThe American journal of tropical medicine and hygiene2026
West Nile Morbidity and Mortality in a Mid-Atlantic Health Care System, 2013-2024.
Article in The American journal of tropical medicine and hygiene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
West Nile virus (WNV) is transmitted by mosquitoes to humans in many regions and can cause neuroinvasive disease and death. To better understand the local burden of disease caused by WNV and risk factors for disease severity, we analyzed cases from across the Johns Hopkins Health System Corporation. We identified 86 patients who met confirmed/probable case definitions for WNV infection from 2013 to 2024. Seventy-one patients (83%) had West Nile neuroinvasive disease (WNND), and nine (10%) died. Encephalitis (n = 47) was the most common complication and was associated with increased age, alcohol use disorder, immunocompromised status, and a higher Charlson Comorbidity Index. Of the 21 patients in the cohort who were immunocompromised, 20 (95%) developed WNND, and 4 (19%) died. The overall median hospital length of stay was 8 days (interquartile range 5-15). People diagnosed with WNV in this health care system experienced significant morbidity and mortality from WNND, notably when immunocompromised.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.